TNK2 and prostate neoplasm: It has been demonstrated that increased expression of ACK1, one of the most remarkable SE-associated genes, overrides the loss of androgen stimulation, and human prostate tumour organoids expressing HOXB13 showed significant resistance to AR antagonists but were sensitive to (R)-9b, an ACK1 selective inhibitor [180].